Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Octagon Capital Advisors »

Mineralys Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Octagon Capital Advisors

Quarter filed	Position value	Share count	Share price at filing
2024-03-31	$7.1M	550k	12.91

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)

Alpine Immune Sciences (ALPN)

Dianthus Therapeutics (DNTH)

Verona Pharma Sponsored Ads (VRNA)

Dyne Therapeutics (DYN)

Arrivent Biopharma

Insmed Com Par $.01 (INSM)

Centessa Pharmaceuticals Sponsored Ads (CNTA)

Eyepoint Pharmaceuticals Com New (EYPT)

Ocular Therapeutix (OCUL)

Structure Therapeutics Sponsored Ads (GPCR)

Bridgebio Pharma (BBIO)

Mind Medicine Mindmed Com New (MNMD)

Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Octagon Capital Advisors

Top funds holding Mineralys Therapeutics

Samsara BioCapital

RA Capital Management

TCG Crossover Management

OrbiMed Advisors

Sr One Capital Management

Adams Street Partners

Laurion Capital Management

Franklin Resources

Rock Springs Capital Management

American Century Companies

Sphera Funds Management

View all funds holding Mineralys Therapeutics

© 2024 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z